| Metric | Current Period | Prior Year Period | YoY |
|---|---|---|---|
| Revenue / Net Sales | ¥4228.1B | ¥3718.8B | +13.7% |
| Operating Income | ¥214.2B | ¥199.5B | +7.4% |
| Ordinary Income | ¥218.3B | ¥204.9B | +6.6% |
| Net Income | ¥153.8B | ¥139.3B | +10.3% |
| ROE | 11.1% | 9.6% | - |
The cumulative Q3 results for FY2026 recorded Revenue of ¥4,228.1B (YoY +¥509.3B +13.7%), Operating Income of ¥214.2B (YoY +¥14.7B +7.4%), Ordinary Income of ¥218.3B (YoY +¥13.5B +6.6%), and Net Income attributable to owners of the parent of ¥153.8B (YoY +¥14.4B +10.3%), achieving three consecutive periods of revenue and profit growth. Top-line maintained double-digit growth driven by aggressive store openings in the drugstore business and expansion of same-store sales. Gross margin inched up to 26.4% (prior 26.3% +0.1pt), supported by an increase in the mix of prescription dispensing and expanded sales of private-brand products. Conversely, SG&A ratio rose to 21.4% (prior 20.9% +0.5pt) as initial costs for new store openings and increases in personnel and logistics costs pressured margins. Operating margin declined to 5.1% (prior 5.4% -0.3pt), but the absolute level of Operating Income reached a record high. Basic EPS was 157.82円 (prior 137.65円 +14.7%), securing double-digit EPS growth, and ROE at 11.1% remains at a healthy level.
Revenue of ¥4,228.1B (+13.7%) was driven by expansion of the store network through accelerated openings and solid performance at existing stores. The business structure consists of a single segment including pharmaceuticals, cosmetics, daily sundries, food, and prescription pharmacy services (neighborhood retail business). Cost of sales was ¥3,110.2B, and gross margin improved by 0.1pt to 26.4% due to a higher proportion of prescription medicines, expanded PB product sales, and improved purchasing negotiation power. Profitability: Gross profit of ¥1,117.9B less SG&A of ¥903.7B yielded Operating Income of ¥214.2B (+7.4%). The rise in SG&A ratio to 21.4% (prior 20.9% +0.5pt; +¥125.6B +16.2% in absolute terms) exceeded the revenue growth rate (+13.7%), mainly due to increases in personnel, logistics and utility expenses and initial costs for new store openings. Non-operating income was ¥17.1B (interest income ¥1.7B, dividend income ¥1.1B, rental income ¥4.8B, etc.), and non-operating expenses were ¥12.9B (interest expenses ¥9.0B, other ¥2.6B). Interest expense doubled from ¥4.5B in the prior year period to ¥9.0B, reflecting the impact of proactive financing for capital expenditures. From Ordinary Income of ¥218.3B (+6.6%), adding Special Income of ¥0.7B (gain on sales of fixed assets ¥0.6B, etc.) and deducting Special Losses of ¥3.0B (loss on retirement of fixed assets ¥1.9B, impairment losses ¥1.1B, etc.) resulted in Profit Before Tax of ¥216.1B. After deducting income taxes of ¥62.3B (effective tax rate 28.8%), Net Income was ¥153.8B (+10.3%), continuing the revenue-and-profit expansion pattern.
Profitability: Operating margin of 5.1% (prior 5.4% -0.3pt) declined due to the rise in SG&A ratio, but a slight increase in gross margin to 26.4% (prior 26.3% +0.1pt) provided support. Net margin was 3.6% (prior 3.7% -0.1pt), with higher interest expense compressing profitability at the ordinary income stage. ROE at 11.1% remains within a healthy range (10–15%); DuPont decomposition is explained by Net Margin 3.6% × Total Asset Turnover 1.09x × Financial Leverage 2.80x. Cash quality: Total Asset Turnover improved to 1.09x (prior 1.06x) as revenue expansion offset asset growth from new stores. Inventory days extended to 72 days (prior 68 days +4 days), indicating a deterioration in inventory efficiency. Payables days of 57 and receivables days of 21 suggest healthy working capital management, but inventory buildup delays cash conversion. Investment efficiency: ROA 4.0% (prior 4.0% unchanged) and ROIC benefited from leverage effects as interest-bearing debt increased, boosting capital efficiency. Financial soundness: Equity Ratio fell to 35.7% (prior 41.4% -5.7pt) due to a large increase in long-term borrowings of ¥1,118.0B (prior ¥783.2B +42.7%). Debt/Equity ratio rose to 1.80x (prior 1.42x) indicating more aggressive leverage, but interest coverage remains strong at 23.7x (Operating Income ¥214.2B ÷ interest expense ¥9.0B). Current ratio is 136.6% (current assets ¥1,563.1B ÷ current liabilities ¥1,144.4B) and quick ratio 83.0%, indicating sufficient short-term liquidity. Cash and deposits of ¥515.8B are 343.9x the short-term borrowings of ¥1.5B, indicating very high short-term payment capacity.
Operating Income ¥214.2B and Net Income ¥153.8B increased YoY, and recurring earnings-generating ability remained solid. In working capital, inventories rose to ¥61,37B (¥613.7B? — preserve original numeric: ¥613.7B) (prior ¥568.1B +8.0%), and the extension of inventory days to 72 days has slowed cash conversion. Although payables at ¥657.3B (prior ¥636.0B +3.3%) balance the inventory increase, there remains significant upside to improve Operating Cash Flow by inventory compression. In investing activities, tangible fixed assets increased to ¥1,887.4B (prior ¥1,688.8B +11.8%), reflecting accelerated new store and renovation investments. Goodwill rose to ¥116.2B (prior ¥101.1B +15.0%), reflecting growth investments such as M&A and remaining at a healthy level of 3.0% of total assets. In financing activities, long-term borrowings increased substantially to ¥1,118.0B (prior ¥783.2B +¥334.8B +42.7%), financing proactive capital investment, while treasury stock balance sharply decreased to ¥25.5B (prior ¥127.5B ▲¥102.0B), indicating treasury stock cancellation or disposal for capital structure adjustment. Interest paid doubled to ¥9.0B (prior ¥4.5B), clarifying the structure where increased borrowings raise interest burden and pressure margins.
(Note: The numeric value for inventories above retains the report's original figure formatting as ¥613.7B.)
Of Operating Income ¥214.2B, Ordinary Income ¥218.3B was formed after non-operating income of ¥17.1B (rental income ¥4.8B, dividend income ¥1.1B, etc.) and non-operating expenses of ¥12.9B (interest expense ¥9.0B), indicating the core of recurring earnings derives from operating business. Special items were limited: Special Income ¥0.7B (gain on sales of fixed assets ¥0.6B) and Special Losses ¥3.0B (loss on retirement of fixed assets ¥1.9B, impairment losses ¥1.1B), with temporary factors reducing pre-tax profit by only -1.1%. Comprehensive income of ¥183.2B exceeded Net Income ¥153.8B by ¥29.4B, mainly due to Other Comprehensive Income from valuation difference on available-for-sale securities of ¥29.5B (prior period ▲¥0.4B, turned positive), increasing equity. From an accrual perspective, the lengthening of inventory days (72 days, prior 68 days) and increase in inventories imply a widening timing gap between profit recognition and cash collection, warranting caution on earnings quality. However, special items are limited and the recurring earnings base is assessed as robust.
Full-year guidance is unchanged at Revenue ¥5,600.0B (YoY +11.7%), Operating Income ¥230.0B (YoY ▲13.5%), Ordinary Income ¥227.0B (YoY ▲17.5%), Net Income attributable to owners of the parent ¥155.0B, forecast EPS 153.31円, and annual dividend of ¥48. Q3 cumulative progress rates are: Revenue 75.5% (standard pace), Operating Income 93.1%, Ordinary Income 96.2%, Net Income 99.2%, indicating profit-side over-performance to date, suggesting either conservative planning anticipating large 4Q capital expenditures and cost postings or the potential for full-year upside. The decline in full-year Operating Income and Ordinary Income forecasts is assumed to reflect one-off 4Q items such as initial costs for store openings, depreciation, personnel costs, and the disappearance of special factors in 4Q of the prior year. Dividend forecast of ¥48 is unchanged, implying a forecast payout ratio of approximately 31% (based on forecast Net Income ¥155.0B), a sustainable level. Considering the Q3 interim dividend of ¥8 per share, the total annual dividend payout is about ¥45.9B, well covered by forecast Net Income.
The Q3 interim dividend of ¥8 per share was paid, and based on an average shares outstanding during the period of 97,432 thousand shares, the total interim dividend amounted to approximately ¥7.8B. The interim payout ratio against cumulative Q3 Net Income ¥153.8B is about 5.1%, indicating a dividend policy prioritizing internal reserves. The full-year dividend forecast of ¥48 corresponds to a forecast payout ratio of 31.3% based on forecast EPS 153.31円, which is sustainable given sector characteristics (retail/store opening investment). The increase from prior-year total dividend of ¥7 to ¥48 (on a full-year basis) signals strengthening shareholder returns while balancing growth investment. Treasury stock balance decreased to ¥25.5B (prior ¥127.5B ▲¥102.0B), reflecting treasury stock cancellation or disposal as a capital structure adjustment, expected to restrain share count dilution and contribute to shareholder value. The total return policy—combining dividends and treasury stock adjustments—appears designed to prioritize store-opening investment while improving capital efficiency and maximizing shareholder value.
Industry positioning (reference, company analysis): Compared with the retail sector median for 2025 Q3, the Company’s Operating margin of 5.1% exceeds the industry median of 3.9% (IQR: 1.2–8.9%), positioning it among the top in profitability. Net margin 3.6% also exceeds the industry median 2.2% (IQR: 0.2–5.7%), indicating relative strength in core profitability. Revenue growth +13.7% far exceeds the industry median +3.0% (IQR: -0.1% to +9.2%), placing the Company among the leaders in growth driven by store openings. ROE 11.1% far exceeds the industry median 2.9% (IQR: 0.5–7.4%), showing superior capital efficiency. Equity Ratio 35.7% is below the industry median 56.8% (IQR: 39.2–64.5%), reflecting a financial strategy that accelerates growth investment through active leverage. Financial leverage 2.80x exceeds the industry median 1.76x (IQR: 1.51–2.55), indicating higher leverage use relative to peers. Inventory days 72 is shorter than the industry median 95.93 days (IQR: 25.57–122.58), suggesting relatively good inventory efficiency, though the YoY extension warrants monitoring. Total Asset Turnover 1.09x exceeds the industry median 0.95x (IQR: 0.77–1.16), indicating superior asset efficiency. Current ratio 136.6% is below the industry median 193% (IQR: 148–273%), but short-term liquidity is adequately secured.
Key points in the earnings are as follows. 1. Sustainability of top-line growth and store opening pace: Revenue growth of +13.7% was achieved by both aggressive openings and strong same-store performance; net increases in store count and the maturation speed of new stores will determine future growth rates. The profit progress rates relative to full-year guidance (Operating 93.1%, Ordinary 96.2%, Net 99.2%) exceeding plan suggest either a conservative assumption anticipating 4Q cost postings or upside risk to the full year; year-end outcomes will be key. 2. Monitor potential inflection in margin trends: Operating margin fell by -0.3pt while gross margin slightly increased, so SG&A control is a precondition for margin recovery. Normalization of inventory days (72 → below 60 days) and stabilization of SG&A ratio (improved existing store efficiency, logistics optimization) would signal margin recovery. 3. Optimization of capital allocation: While long-term borrowings rose +42.7% to support active investment, the reduction of treasury stock by ¥102.0B and maintenance of ROE 11.1% indicate improved capital efficiency via leverage. Forecast payout ratio ~31% is sustainable, and the balance between growth investment and shareholder returns is generally appropriate. However, rising interest rates and deteriorating inventory efficiency will test the sustainability of FCF generation.
This report is an earnings analysis document automatically generated by AI analyzing XBRL earnings disclosure data. It does not constitute a recommendation to invest in any particular security. Industry benchmarks are reference information aggregated by our firm based on public financial statements. Investment decisions should be made at your own responsibility, and if necessary, after consulting a professional.